Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-359P (RNA, U6 small nuclear 359, pseudogene) is a human pseudogene and non-coding RNA locus. It is annotated as a member of the U6 family of small nuclear RNA (snRNA) pseudogenes, which are non-functional copies of genes originally coding for components of the spliceosomal machinery. Unlike functional U6 snRNA genes, RNU6-359P does not encode an active RNA molecule and does not possess a known biological or regulatory function. As a pseudogene, it does not produce protein or functional RNA and is not considered a therapeutic or drug target. There are no documented disease associations, interacting drugs, biomarker roles, or safety considerations relating to this pseudogene[1][3]. RNU6-359P is not a protein, enzyme, transporter, receptor, or otherwise actionable therapeutic target. Being a pseudogene, it is typically regarded as a genomic "fossil" and lacks regulatory or functional roles that would make it suitable for targeting in drug development[1][3]. The gene has no current relevance as a biomarker or clinical entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 359, pseudogene (RNU6-359P).